✦ LIBER ✦

We-P11:1 Reducing the cardiovascular risk at patients with type 2 diabetes by controlling the risk factors

✍ Scribed by Tudor, C.; Jeberean, R.A.; Buzas, R.; Popescu, A.; Ionita, M.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cardiovascular risk factors in patients

✍ Francisco Javier del Cañizo-Gómez; Marı́a Natividad Moreira-Andrés 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 120 KB

ROLE OF FENOFIBRATE IN THE RISK FACTORS

✍ Ikramova, B.R.; Akbarova, N.M.; Rakhimova, N.M. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 115 KB

We-P11:19 Assessment of von willebrand f

✍ Kapoor, R.; Kapoor, A.; Gill, K.S. 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 155 KB

P79 ATHEROSCLEROTIC DISEASE LOCATION AND

✍ Gouni-Berthold, I.; Bestehorn, K.; Krone, W.; Berthold, H.K. 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Treatment gaps in the management of card

✍ Manoela F.B. Braga; Amparo Casanova; Hwee Teoh; Keith G. Dawson; Hertzel C. Gers 📂 Article 📅 2010 🏛 Pulsus Group Inc 🌐 English ⚖ 236 KB

Primacy of the 3B Approach to Control Ri

✍ Ji, Linong; Hu, Dayi; Pan, Changyu; Weng, Jianping; Huo, Yong; Ma, Changsheng; M 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 893 KB